Medindia

X

Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products

Wednesday, September 5, 2007 General News J E 4
Advertisement
WARSAW, Ind. and ALACHUA, Fla., Sept. 4 ZimmerHoldings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry,and Tutogen Medical, Inc., a leading manufacturer of sterile biologicalimplant products made from human (allograft) and animal (xenograft) tissue,today announced the expansion of Tutogen's partnership with Zimmer DentalInc., a wholly owned subsidiary of Zimmer Holdings, Inc., into Europe, theMiddle East and Asia. Zimmer Dental currently distributes Tutogen grafts inthe United States, Canada and Latin America, under the brand name Puros(R).This enhanced distribution agreement includes both human and bovine tissues --bone and soft tissue grafts -- and provides the dentist with a completeproduct package for the regenerative procedure.

According to David Dvorak, President and Chief Executive Officer of ZimmerHoldings, Inc., Zimmer Dental's parent company, "We look forward to leveragingthe success and experience that we have achieved in the U.S. market with Purosdental products from Tutogen. This is an outstanding international marketopportunity for Zimmer Dental as it enables us to continue to define ourselvesas an innovator in advanced materials and in state-of-the-art oralrehabilitation technologies."

Guy Mayer, President and Chief Executive Officer of Tutogen Medical,commented, "Our dental products have demonstrated superior clinical results inthe U.S. market. We look forward to extending our relationship with ZimmerDental in globalizing this fast growing product portfolio. Working togetherwe have a demonstrated track record of success in developing the NorthAmerican market. We believe that joint experience provides a strongfoundation to build a significant international business."

The addressable market for Tutogen's dental products is estimated to beapproximately $300 million annually, with the U.S. representing approximatelyone-half of the total.

About Puros

According to the companies, the Puros family of bone grafting productsoffers an effective and predictable clinical outcome for patients requiringbony enhancement of the mandible and maxilla in a timely manner. All Purosproducts feature easy handling, quick hydration, five-year shelf life and roomtemperature storage.

About Zimmer

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is theworldwide #1 pure-play orthopaedic leader in designing, developing,manufacturing and marketing reconstructive and spinal implants, trauma andrelated orthopaedic surgical products. Zimmer has operations in more than 24countries around the world and sells products in more than 100 countries.Zimmer's 2006 sales were approximately $3.5 billion. Zimmer is supported bythe efforts of more than 7,000 employees worldwide.

Visit Zimmer on the worldwide web at www.zimmer.com

About Zimmer Dental Inc.

Zimmer Dental is a global leader in the oral rehabilitation market with amission to improve the lives of patients through continuous productdevelopment and leadership in education. Zimmer Dental offers one of the mostcomprehensive dental implant product lines available, including the TaperedScrew-Vent(R) Implant System and Puros Allograft family, and providesprofessionals access to premier education and training resources such as TheZimmer Institute(TM).

About Tutogen Medical, Inc.

Tutogen Medical, Inc. manufactures sterile biological implant productsmade from human (allograft) and animal (xenograft) tissue. Tutogen utilizesits proprietary Tutoplast Process(R) of tissue preservation and viralinactivation to manufacture and deliver sterile bio-implants used inspinal/trauma, urology, dental, ophthalmology, and general surgery procedures.Tutogen's Tutoplast(R) products are sold and distributed worldwide by ZimmerSpine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc.subsidiary of C.R. Ba
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mediware Names Thomas K. Mann Chief Executive Offi...
S
Regence Offers InterM to Fill Gap for the Uninsure...